Relay Therapeutics Shares Rise In Pre-Market Ahead Of Key Drug Update
Shares of Relay Therapeutics Inc. traded higher in early premarket Tuesday. The Cambridge biotech said its top drug zovegalisib showed initial signs of shrinking lesions in patients with rare vascular anomalies.